Prostate Carcinoma Hormone Therapy
Hormone therapy for prostate cancer can stop cancer cells from growing. The male hormone, testosterone, is usually necessary for prostate cancer to grow. Depriving prostate cancer cells of testosterone can stop their growth for a period of time.
Prostate cancer hormone therapy medications include:
- Leuprolide (Lupron)
- Goserelin (Zoladex)
- Abarelix (Plenaxis)
- Reduces the amount of testosterone that is produced by the body.
- Bicalutamide (Casodex)
- Nilutamide (Nilandron)
- Finasteride (Proscar)
- Flutamide (Eulexin)
Complications of hormone therapy include:
Continue to Prostate Carcinoma Monitoring
- Alibhai SM, Klotz LH. A systematic review of randomized trials in localized prostate cancer. Can J Urol. 2004 Feb;11(1):2110-7. 
- Astorg P. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control. 2004 May;15(4):367-86. 
- Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int. 2004 May;93(8):1139-50. 
- Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int. 2003 Jun;91(9):789-94. 
- Mahmud S, Franco E, Aprikian A. Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis. Br J Cancer. 2004 Jan 12;90(1):93-9.